LY-2562175

N/A

Report date: 2023/04/06 15:44:52
NME

Base Information

Drug NameLY-2562175
Drug Alias NameLY-2562175TERN-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBile acid receptor FXR agonists
TargetsBile acid receptor FXR
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseCholangitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesEli Lilly And Company
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Terns Biological Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseCholangitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A